TP53BP1 and cancer: Using immunofluorescence staining with anti-γH2AX and 53BP1 antibodies, it has been shown that residual γH2AX/53BP1 lesions after irradiation were more pronounced in HPV-positive cancer cells indicating alteration of homologous recombination and nonhomologous end-joining [18, 19].